Navigation Links
Ohr Pharmaceutical Announces Approval for Listing on NASDAQ
Date:6/12/2013

NEW YORK, June 12, 2013 /PRNewswire/ -- Ohr Pharmaceutical, Inc. (OTCQB: OHRPD), a pharmaceutical company focused on the development of novel therapeutics for large unmet medical needs, today announced that it has received confirmation that its application to list the company's common stock on the NASDAQ Capital Market has been approved by The NASDAQ Stock Market, a unit of the NASDAQ OMX Group. In honor of the listing, the Company will ring the Opening Bell at the NASDAQ MarketSite in Times Square, New York City, on Thursday, June 13 (Link to the live webcast beginning at 9:20am ET).

Ohr's common stock is expected to begin trading on the NASDAQ Capital Market at the opening of trading on June 13, 2013 under the ticker symbol, OHRP. The Company's common stock will continue to trade on the Over-the-Counter Bulletin Board until the market close on June 12, 2013 under the ticker symbol, OHRPD.

"Our listing on the NASDAQ Capital Market is a major corporate milestone for our Company and a testament to the tremendous progress we have made over the past few years," stated Dr. Irach Taraporewala, CEO of Ohr Pharmaceutical. "We believe that the listing on NASDAQ will help broaden our shareholder base, increase appeal to institutional investors, provide us with better liquidity and ultimately contribute to increasing shareholder value. We continue to execute on our clinical and corporate strategy, and anticipate achieving 50% enrollment of the Squalamine Eye Drop phase II wet-AMD trial in the near term, as per our previous guidance."

About Ohr Pharmaceutical, Inc.
Ohr Pharmaceutical, Inc. (OTCQB: OHRPD) is a pharmaceutical company dedicated to the clinical development of new drugs for underserved therapeutic needs in large and growing markets. The Company is focused o
'/>"/>

SOURCE Ohr Pharmaceutical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. GDS International Leads the Way for the Pharmaceutical Industry at its Upcoming NGP DD 30 Summit in Madrid
2. Pointlogic and Kantar Media Announce Dedicated Communication Planning Solution for Pharmaceutical Industry
3. The Top Five Global Pharmaceutical Companies: Performance, Strategies and Competitive Analysis
4. Breckenridge Pharmaceutical signs Letter of Intent with Welding GmbH & Co & SK Chemicals
5. Pharmapack North America - Event to Cover Drug Security, Track and Trace, Pharmaceutical Packaging Design and Patient Compliance
6. Adamas Pharmaceuticals To Report Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia In Parkinsons Disease
7. Access Pharmaceuticals Signs US License Agreement With AMAG Pharmaceuticals For MuGard
8. HemaQuest Pharmaceuticals Completes Patient Enrollment in Phase 2b Clinical Study of HQK-1001 in Patients with Sickle Cell Disease
9. Oramed Pharmaceuticals to Present at IATI-BioMed Conference in Israel
10. DelMar Pharmaceuticals, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
11. Valeant Pharmaceuticals Announces Filing Of Preliminary Base Shelf Prospectus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 2014  A Boston Scientific Corporation (NYSE: ... removability and preliminary long term stricture resolution of ... August issue of the peer-reviewed journal, Gastroenterology. ... being conducted in 11 countries and five continents, ... stents (FCSEMS) after extended indwell (i.e., up to ...
(Date:8/29/2014)... Aug. 29, 2014   Mast Therapeutics, Inc. ... announced today that Santosh Vetticaden, Chief Medical Officer ... Company, for personal reasons, in mid-September.  Edwin ... of Aires Pharmaceuticals, which Mast acquired earlier this ... the Company,s interim Chief Medical Officer.  Dr. Parsley ...
(Date:8/29/2014)... 2014 Medina Medical announced today that Mr. ... the Board of Directors on August 18, 2014. Mr. ... commercialization experience, including over a decade of direct experience ... a Partner of the medical device incubator The Foundry, ... Foundry start-ups. Mr. Engelson previously served as the Chief ...
Breaking Medicine Technology:Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 3Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 4Mast Therapeutics Announces Management Change 2Mast Therapeutics Announces Management Change 3Mast Therapeutics Announces Management Change 4Medina Medical Announces Erik T. Engelson Joins as Chief Executive Officer 2
... 2011 IVD Technology , a UBM Canon medical ... webcast on Challenges in Clinical Lab Automation and IVD ... take place on May 26, 2011 at 2:00 p.m. ET ... here . (Logo:   http://photos.prnewswire.com/prnh/20101214/LA16070LOGO ) ...
... BioPharma, Inc. (PBI) and Gilead Sciences, Inc. will be ... in Pulmonary Fibrosis" session at the 2011 American Thoracic ... 18, 2011.  The poster entitled Differing Effects of ... Following Bleomycin Instillation will be presented by John ...
Cached Medicine Technology:IVD Technology Announces Educational Lecture Webcast: Challenges in Clinical Lab Automation and IVD Instrumentation Development 2Plato BioPharma Presenting Poster at the American Thoracic Society Conference 2
(Date:8/29/2014)... Healthpointe is pleased to provide ... students via Clinical Rotations. Physical Therapy ... Healthpointe providers and specialists throughout their daily clinical ... experience and learn professional preparation. , ... into several patient care techniques and expand their ...
(Date:8/29/2014)... Highly regarded audiologist , Dr. Mary Ann Larkin has written ... reports are titled:, , Revealing the Truth About ... The Top 5 Things You Should Know Before Buying ... Children , Dr. Mary Anne Larkin choose to write ... and misinformation about each them. The reports are available for ...
(Date:8/29/2014)... 29, 2014 (HealthDay News) -- Astronauts may be ... to disrupt human immune systems, a new study suggests. ... long missions to asteroids, the moon and Mars undertaken ... while in space can be dangerous, NASA researchers say. ... in the blood of International Space Station crew members ...
(Date:8/29/2014)... 2014 Healthpointe is pleased to announce ... their practice. Dr. Chuang garners extensive experience in the ... arthroscopic and reconstructive treatments of the knees, hips, and ... general and sports-related orthopedic needs. , Dr. ... As an Orange County native, he graduated with two ...
(Date:8/29/2014)... IL (PRWEB) August 29, 2014 Pursuing ... is set to unveil a stunning new design ... to company figures, the highly notable surrogacy platform has ... January. With over 13,000 visitors a month, the FindSurrogateMother.com ... mothers working toward one common goal — the precious ...
Breaking Medicine News(10 mins):Health News:Healthpointe is Now Offering Clinical Rotations for Chapman University Physical Therapy Students 2Health News:Charleston SC Audiologist, Dr. Mary Ann Larkin Authors Four New Special Reports on Important Hearing Healthcare Topics 2Health News:Charleston SC Audiologist, Dr. Mary Ann Larkin Authors Four New Special Reports on Important Hearing Healthcare Topics 3Health News:Spaceflight Might Weaken Astronauts' Immune Systems 2Health News:Healthpointe is Honored to Induct Orthopedic Surgeon into Their Team 2Health News:FindSurrogateMother.com Set to Unveil Stunning New Design as Member Sign-ups Increase by 42% since January 2Health News:FindSurrogateMother.com Set to Unveil Stunning New Design as Member Sign-ups Increase by 42% since January 3
... Heart Rate Monitor Technology Now Available in ... Commercial Fitness ... the leader in,heart rate monitoring and fitness assessment technology, announced ... heart rate monitors -- can now be seamlessly and cost-effectively,incorporated ...
... September 24, Nominations Now Being,Accepted, NEW YORK, ... Carl M. Loeb University Professor Emeritus at Harvard,University ... Laureates on the,committee responsible for awarding the most ... http://www.prix-galien-usa.com ) will be held on Wednesday, September ...
... April 14 Denise Kehoe has joined,medication therapy ... development. In her new role, she will manage ... of clients across the country., Kehoe brings ... and,operations experience to PharmMD. She recently served as ...
... reveals some promising substance use trends among Ontario adults, its ... significant public health flag. , First the more positive ... significantly declining from 28 percent in 1996 to 20 percent ... from 13 percent in 1996 to just 6 percent in ...
... National,Community Pharmacists Association (NCPA), representing approximately 23,000,independent ... about,pharmacy crime and offering tangible solutions during ... 18). At the forefront of the campaign ... Enforcement Executive Development,Association), and RxPatrol(R) from Purdue ...
... NEW YORK, April 14 When it comes ... often used,interchangeably, often confusing consumers. The Physicians Coalition ... "A label containing specific consumer safety information ... a drug or medical device has been,approved," explained ...
Cached Medicine News:Health News:Polar Introduces Cost-Effective Solution to Reduce Heart Rate Data Cross-Talk 2Health News:Prix Galien USA Welcomes Eighth Nobel Laureate to its Prestigious Award Committee 2Health News:Prix Galien USA Welcomes Eighth Nobel Laureate to its Prestigious Award Committee 3Health News:PharmMD Announces Denise Kehoe as Vice President of Business Development 2Health News:Marijuana use on the rise among Ontario adults, CAMH reports 2Health News:NCPA Declares April 14 - 18 'Protect Your Pharmacy Week' 2Health News:Clarity on Cosmetic Injectable Labeling and Use 2Health News:Clarity on Cosmetic Injectable Labeling and Use 3
The Trans-Blot transfer cell, used with the included PowerPac 200 power supply, performs efficient, high-intensity electrophoretic transfers. The Trans-Blot cell offers many advantages....
... for a Range of ... Native Enzyme, High Intensity, ... Faster, Higher-Efficiency Transfers via ... Field-Intensity Transfers with Movable ...
... Includes: Criterion cell for running ... with plate electrodes. A blotter fit ... Criterion precast gel system, the Criterion ... the flexibility of the Trans-Blot system ...
A blotter fit for use with the incredible new Criterion precast gel system, the Criterion blotter combines excellent blotting efficiency with the flexibility of the Trans-Blot system and the ease-of-...
Medicine Products: